🔎 Trials Near Me

Beranda › Obesitas › Florida › Jacksonville

Uji klinis Obesitas di Jacksonville, FL

25 studi untuk Obesitas mencari peserta di lokasi sekitar Jacksonville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 2
  • Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Menerima pesertaFase 3
  • Jacksonville Ctr Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Menerima pesertaFase 3
  • Jacksonville Ctr for Clin Res, Jacksonville
Usia 8 hingga 18 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07253285

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Menerima pesertaFase 2
  • Flourish Research, Jacksonville Center for Clinical Research, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Menerima pesertaFase 3
  • Jacksonville Ctr Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Menerima pesertaFase 3
  • Jacksonville Ctr Clin Res, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07668414

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Jacksonville
  • Research Site, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Menerima pesertaFase 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Fleming Island Center for Clinical Research, Fleming Island · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Menerima pesertaFase 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Northeast Research Institute (NERI), Fleming Island · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Menerima pesertaFase 3
  • Research Site, Fleming Island · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • East Coast Institute for Research, LLC, Jacksonville
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Menerima pesertaFase 3
  • Westside Center for Clinical Research, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07353931

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

Menerima pesertaStudi observasional
  • Nemours Children's Clinic, Jacksonville
Usia 12 hingga 18 · Wanita · Diperbarui 18 Sep 2026 · NCT07169136

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 3
  • AURORA-1 Clinical Site, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Menerima pesertaFase 3
  • East Coast Institute for Research, Jacksonville
  • First Coast Cardiovascular Institute PA, Jacksonville
  • Jacksonville Center for Clinical Research, Jacksonville
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Jacksonville
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Clinical Neuroscience Solutions - Jacksonville, Jacksonville
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07784725

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

Menerima pesertaFase 4Sukarelawan sehat diterima
  • Mayo Clinic in Florida, Jacksonville
Usia 46 hingga 60 · Wanita · Diperbarui 18 Agu 2026 · NCT07218445

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Menerima pesertaFase 3
  • Jacksonville Ctr for Clin Res, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Menerima pesertaFase 3
  • Westside Center For Clinical Research, Jacksonville
  • Clinical Neuroscience Solutions, LLC, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07509307

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Menerima pesertaFase 3
  • CNS Healthcare, Jacksonville
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT07481630

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Menerima pesertaFase 1
  • Jacksonville Ctr For Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT07607587

Knee Injections for Obese Patients With Knee Arthritis

Menerima pesertaFase 4
  • Mayo Clinic in Florida, Jacksonville
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT06782529

Uji klinis Obesitas di kota lain

Studi lain di Jacksonville

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.